482 related articles for article (PubMed ID: 24152895)
21. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.
Jansook P; Pichayakorn W; Muankaew C; Loftsson T
Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786
[TBL] [Abstract][Full Text] [Related]
22. A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.
Lakkakula JR; Maçedo Krause RW
Nanomedicine (Lond); 2014 May; 9(6):877-94. PubMed ID: 24981652
[TBL] [Abstract][Full Text] [Related]
23. Formation, characterization, and fate of inhaled drug nanoparticles.
Zhang J; Wu L; Chan HK; Watanabe W
Adv Drug Deliv Rev; 2011 May; 63(6):441-55. PubMed ID: 21118707
[TBL] [Abstract][Full Text] [Related]
24. Cyclodextrin-based nanosponges: a propitious platform for enhancing drug delivery.
Chilajwar SV; Pednekar PP; Jadhav KR; Gupta GJ; Kadam VJ
Expert Opin Drug Deliv; 2014 Jan; 11(1):111-20. PubMed ID: 24298891
[TBL] [Abstract][Full Text] [Related]
25. Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity.
Swaminathan S; Pastero L; Serpe L; Trotta F; Vavia P; Aquilano D; Trotta M; Zara G; Cavalli R
Eur J Pharm Biopharm; 2010 Feb; 74(2):193-201. PubMed ID: 19900544
[TBL] [Abstract][Full Text] [Related]
26. High melting lipid based approach for drug delivery: solid lipid nanoparticles.
Kumar S; Randhawa JK
Mater Sci Eng C Mater Biol Appl; 2013 May; 33(4):1842-52. PubMed ID: 23498204
[TBL] [Abstract][Full Text] [Related]
27. Protein-coated nanoparticles embedded in films as delivery platforms.
Morales JO; Ross AC; McConville JT
J Pharm Pharmacol; 2013 Jun; 65(6):827-38. PubMed ID: 23647676
[TBL] [Abstract][Full Text] [Related]
28. Nanosponge-based pediatric-controlled release dry suspension of Gabapentin for reconstitution.
Rao MR; Bhingole RC
Drug Dev Ind Pharm; 2015; 41(12):2029-36. PubMed ID: 26006328
[TBL] [Abstract][Full Text] [Related]
29. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
30. Cyclodextrins in drug delivery.
Loftsson T; Jarho P; Másson M; Järvinen T
Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
[TBL] [Abstract][Full Text] [Related]
31. Pharmaceutical applications of cyclodextrins: basic science and product development.
Loftsson T; Brewster ME
J Pharm Pharmacol; 2010 Nov; 62(11):1607-21. PubMed ID: 21039545
[TBL] [Abstract][Full Text] [Related]
32. Drug-in-cyclodextrin-in-liposomes: a promising delivery system for hydrophobic drugs.
Chen J; Lu WL; Gu W; Lu SS; Chen ZP; Cai BC; Yang XX
Expert Opin Drug Deliv; 2014 Apr; 11(4):565-77. PubMed ID: 24490763
[TBL] [Abstract][Full Text] [Related]
33. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
Bikiaris DN
Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
[TBL] [Abstract][Full Text] [Related]
34. Cyclodextrin nanosystems in oral drug delivery: A mini review.
Adeoye O; Cabral-Marques H
Int J Pharm; 2017 Oct; 531(2):521-531. PubMed ID: 28455134
[TBL] [Abstract][Full Text] [Related]
35. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
Wang XQ; Zhang Q
Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
[TBL] [Abstract][Full Text] [Related]
36. Development of a new delivery system consisting in 'drug-in cyclodextrin-in PLGA nanoparticles'.
Mura P; Maestrelli F; Cecchi M; Bragagni M; Almeida A
J Microencapsul; 2010; 27(6):479-86. PubMed ID: 20113170
[TBL] [Abstract][Full Text] [Related]
37. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, characterization and application of epichlorohydrin-β-cyclodextrin polymer.
Gidwani B; Vyas A
Colloids Surf B Biointerfaces; 2014 Feb; 114():130-7. PubMed ID: 24185192
[TBL] [Abstract][Full Text] [Related]
39. Cyclodextrin-based nanosponges as drug carriers.
Trotta F; Zanetti M; Cavalli R
Beilstein J Org Chem; 2012; 8():2091-9. PubMed ID: 23243470
[TBL] [Abstract][Full Text] [Related]
40. New challenges for pharmaceutical formulations and drug delivery systems characterization using isothermal titration calorimetry.
Bouchemal K
Drug Discov Today; 2008 Nov; 13(21-22):960-72. PubMed ID: 18617012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
